Material requirement for the delivery of antibody and antigen supply.
Active Indefinite Delivery Contract Awarded Last action
- Contract number
- HT942525D0009
- Awardee
-
Mapp Biopharmaceutical, Inc. UEI M9V9QTHR1H28
- Awarding agency
-
Defense Health Agency
Department of Defense
- Task orders
- 4 $201,750 obligated
Award facts
- Opportunity
-
- HT942525R0047 Solicitation number
- Combined order value
- $201,750 Current and potential, with all options
- Last date to order 28% complete
- IDV ceiling 10% used
- $2,000,000.00
- Maximum order
- $2,000,000.00
- Award type
- Single award
- Who can order
- Only the awarding agency
- Contracting staff
- NAICS code
- 325413 In-Vitro Diagnostic Substance Manufacturing
- Set-aside
- No set-aside
- Competition
- Not Competed under SAP · 1 offer Simplified Acquisition
- Pricing
- Firm Fixed Price
Award details come from SAM.gov/FPDS.
About this IDV
The Defense Health Agency awarded a single-award indefinite-delivery contract to Mapp Biopharmaceutical, Inc. for $2 million, effective June 1, 2025, through May 31, 2030, to procure human-derived monoclonal antibodies and viral recombinant antigens. No set-aside applies to this vehicle.
Work is performed in San Diego, California. The contract supports the Defense Health Agency's medical countermeasures and military medical preparedness mission through flexible task order placement as immunotherapy and antigen needs emerge.
Since award, the Defense Health Agency has issued four delivery orders under this IDIQ. The largest, awarded June 6, 2025, carried a ceiling of $110.5 million for supply of monoclonal antibodies and viral recombinant antigens, with completion scheduled for December 4, 2025. A second order, awarded September 19, 2025, was valued at $60,500 with completion February 25, 2026. A third, awarded February 6, 2026, was valued at $20,500 with completion April 24, 2026. A fourth order, awarded July 2, 2026, carried a ceiling of $10,250 with completion October 1, 2026. All delivery orders use firm fixed-price pricing and carry no set-aside designation. Place of performance for all orders is San Diego, CA 92121.
Task orders
| Task order | Ordering agency | Obligated | Awarded |
|---|---|---|---|
| Procurement of human derived monoclonal antibodies and recombinant antigens | Defense Health Agency | $10,250 | |
| Procurement of human derived monoclonal antibodies and antigens | Defense Health Agency | $20,500 | |
| Human-derived monoclonal antibodies and recombinant antigens | Defense Health Agency | $60,500 | |
| Antibody & antigen supply | Defense Health Agency | $110,500 |
Transactions
| Action | Obligated | Date |
|---|---|---|
| Supplemental Agreement for work within scope | $0 | |
| Other Administrative Action | $0 | |
| Other Administrative Action | $0 | |
| Original award | $0 |
Quick answers
Who was awarded contract HT942525D0009?
HT942525D0009 was awarded to Mapp Biopharmaceutical, Inc. by Defense Health Agency (Department of Defense) on June 1, 2025.
How much is contract HT942525D0009 worth?
Orders under HT942525D0009 have obligated $201,750. HT942525D0009's own ceiling is $2,000,000. A single order can be worth up to $2,000,000.
How many orders have been placed under contract HT942525D0009?
4 orders have been placed under HT942525D0009, the latest on July 2, 2026.
Who can order from contract HT942525D0009?
HT942525D0009 is a single award indefinite delivery contract. Only the awarding agency can place orders on it.
Was contract HT942525D0009 competed?
The extent of competition for HT942525D0009 was not competed under sap. The government received 1 offer.
On GovTribe
See this IDV's full record
- Every order and transaction
- The awardee's other awards and teaming partners
- Similar IDVs and recompete opportunities
- Ask GovTribe AI about this IDV